Biallelic loss of function variants in
WBP4
pre-mRNA splicing
spliceosome
syndromic neurodevelopmental disorder
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
27 Jun 2023
27 Jun 2023
Historique:
pubmed:
10
7
2023
medline:
10
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Over two dozen spliceosome proteins are involved in human diseases, also referred to as spliceosomopathies. WBP4 (WW Domain Binding Protein 4) is part of the early spliceosomal complex, and was not described before in the context of human pathologies. Ascertained through GeneMatcher we identified eleven patients from eight families, with a severe neurodevelopmental syndrome with variable manifestations. Clinical manifestations included hypotonia, global developmental delay, severe intellectual disability, brain abnormalities, musculoskeletal and gastrointestinal abnormalities. Genetic analysis revealed overall five different homozygous loss-of-function variants in
Identifiants
pubmed: 37425688
doi: 10.1101/2023.06.19.23291425
pmc: PMC10327195
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NICHD NIH HHS
ID : K23 HD102589
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Commentaires et corrections
Type : UpdateIn
Déclaration de conflit d'intérêts
DECLARATION OF INTERESTS HMS is an employee of Geneyx Genomics. Other authors declare no conflict of interest.